RJF
RAYMOND JAMES FINANCIAL INCEvidence as of 2026-09-03Overview · RAYMOND JAMES FINANCIAL INC
Raymond James Financial, Inc., a diversified financial services company, provides private client group, capital markets, asset management, banking, and other services to individuals, corporations, and municipalities in the United States, Canada, and Europe. The Private Client Group segment offers investment services, portfolio management services, insurance and annuity products, and mutual funds; support to third-par…
Management team
- Ms. Kristina Waugh · Senior Vice President of Investor Relations and FP&AFind on LinkedIn
- Andy Zolper · Chief information officerFind on LinkedIn
- Mr. Vin Campagnoli · EVP of Technology & OperationsFind on LinkedIn
- Mr. Paul Marone Shoukry · CEO & DirectorFind on LinkedIn
Start your 7-day free trial to see the full management team.
Links open LinkedIn searches, not verified profiles. Team data from our market-data vendor's company profile.
Moneyta sentiment
Where the published evidence leans after the desk debated it — not a rating or a recommendation.
+0.3 on a −2 to +2 scale.
What builds the score
Solid bars are analyst rubric scores; faded bars are computed directly from data. Claims dropped in debate count for nothing; weakened claims count at half weight.
Editor's note
Written after the debate settled — the rest of the page is the evidence behind it.
The desk’s surviving evidence presents a Mixed picture (+ 0.3 of a possible + 2; was + 0.3 before debate) with high confidence. Revenue rose sequentially across the most recent reported fiscal quarters: $ 4,035,000,000 in fiscal Q1 2026 (fiscal quarter ended 2026-02-04), $ 4,262,000,000 in fiscal Q2 2026 (fiscal quarter ended 2026-05-04), and $ 4,362,000,000 in fiscal Q3 2026 (fiscal quarter ended 2026-08-03). Diluted EPS fell from $ 2.86 in fiscal Q1 2026 to $ 2.36 in fiscal Q2 2026 and then rose to $ 3.01 in fiscal Q3 2026, while net income moved from $ 600,000,000 to $ 495,000,000 and back to $ 595,000,000 over the same sequence.
Shares outstanding show a clear contraction: weighted-average diluted shares of 209,200,000 in fiscal Q1 2026, 199,200,000 in fiscal Q2 2026, and 197,200,000 in fiscal Q3 2026, and point-in-time shares of 197,091,037 as of 2026-02-04, 194,883,034 as of 2026-05-04, and 192,361,711 as of 2026-08-03. Balance-sheet aggregates likewise rose across the reported dates: liabilities of $ 76,186,000,000 as of 2024-12-31, $ 79,334,000,000 as of 2026-03-31, and $ 81,454,000,000 as of 2026-06-30, and assets of $ 88,760,000,000, $ 91,944,000,000, and $ 94,237,000,000 on those same dates. Valuation and liquidity snapshots include a trailing twelve-month P/E of 16.54, trailing twelve-month free cash flow of negative $ 1,937,000,000 (FCF per share negative $ 9.8225), cash and cash equivalents of $ 9,977,000,000 as of 2026-06-30, market cap $ 33,846,043,050 and enterprise value $ 23,869,043,050 (price date 2026-09-02).
How this note was made
every stage ran before the note was writtenAnalyst desk
Mercer, Oakes, Nash, Ellis, Yates, Talbot and Archer. The desk: named AI agents, not people. Each reads one slice of the evidence and nothing else — no outside knowledge, no browsing — so every finding traces to a source you can open.
Reads the XBRL figures companies file with the SEC — revenue, margins, income, debt and share count, quarter by quarter — and reports which way the trend is running.
Revenue rose sequentially across the most recent fiscal quarters reported: $4,035,000,000 in fiscal Q1 2026 (2024-10-01 to 2024-12-31), $4,262,000,000 in fiscal Q2 2026 (2026-01-01 to 2026-03-31), and $4,362,000,000 in fiscal Q3 2026 (2026-04-01 to 2026-06-30).
XBRL companyfacts · 0000720005-26-000035Diluted earnings per share moved from $2.86 in fiscal Q1 2026 (2024-10-01 to 2024-12-31) to $2.36 in fiscal Q2 2026 (2026-01-01 to 2026-03-31) and then to $3.01 in fiscal Q3 2026 (2026-04-01 to 2026-06-30).
XBRL companyfacts · 0000720005-26-000035Reads the filings themselves, above all the year-over-year diff of Item 1A risk factors: which risks a company added, dropped or quietly reworded since its last annual report.
Which filings the desk reads
The desk reads the annual 10-K in full — its risk factors, and how they changed since last year. Quarterly 10-Qs and event filings (8-Ks, insider Form 4s) are listed for context but not read line by line: the 10-K is where the material risk disclosures live. A brand-new company, or one we have only just begun tracking, may have no annual report on file yet — its risk analysis fills in once that lands.
An 8-K filing with the 8-K filed 1 September 2026 was submitted on 1 September 2026 and is present in the provided evidence.
8-K filed 2026-09-01The provided evidence entry for the 8-K shows its parse_status as 'pending' and lists no primary document URL, indicating the filing content was not available for review in this data set.
8-K filed 2026-09-01Reads the signal panel above — momentum, volatility, drawdown, relative strength and beta — and ranks each against the whole research universe rather than judging it in isolation.
No computed signal history for this symbol yet — signals need roughly 70 trading days of price history.
Reads which funds hold the name and at what weight, plus insider Form 4 filings, to show the exposure you may already carry through index funds.
As of 2026-09-02T13:45:47.228469+00:00, Raymond James Financial Inc (RJF) is a constituent holding in the iShares Core S&P 500 ETF (IVV).
ETF constituents · market dataRJF's reported weight in IVV is 0.04% of the fund as of 2026-09-02T13:45:47.228469+00:00.
ETF constituents · market dataReads recent headlines that are genuinely about this company, ignoring rating chatter and market-wide stories. Findings argue in the debate but never move the sentiment score.
Recent headlines exist but none are company-specific — market-wide stories and rating chatter are excluded.
Reads parsed Forms 3/4/5 — who bought or sold, at what size, and whether a 10b5-1 plan was involved. Flags clustered open-market officer buying; treats plan sales as routine and never counts a fund or 10%-holder as an officer.
No insider transactions on file in the trailing 180 days.
Reads the implied-expectations math built from the company's own filings (the growth rate today's price would justify, and the multiples beside it) and argues whether the market's bar looks high or low for this business. Never turns the math into a target.
The trailing twelve-month price-to-earnings ratio reported is 16.54.
Valuation inputs · SEC XBRL + stored EOD closeTrailing twelve-month free cash flow (FCF) is negative $1,937,000,000.
Valuation inputs · SEC XBRL + stored EOD closeDebate and risk review
A bull and a bear contest the claims and the chair rules on each; the risk review stress-tests what survived.
A bull and a bear argue the analysts' claims across two rounds, then a chair rules on each one. Only what survives feeds the score — the argument is shown, not hidden, so you can judge the reasoning yourself.
Several contemporaneous data points in the filing-derived evidence support a favorable operational read: sequential quarterly revenue growth (fundamentals-0), an uptick in diluted EPS in the most recent quarter after a mid-period dip (fundamentals-1 and fundamentals-2), and a clear reduction in shares outstanding across both weighted-average diluted shares and point-in-time counts (fundamentals-3 and fundamentals-4) consistent with share repurchase activity. These items, combined with a reported cash balance near $10.0B and no recorded long-term debt in the data snapshot (valuation-3), strengthen the case that earnings per share dynamics have been aided by capital returns and a solid liquidity position. The negative trailing twelve-month free cash flow (valuation-1, valuation-2) is a material counterpoint; however, the evidence for large cash reserves and shrinking share count provides context that mitigates that concern to some degree. The pending/empty 8-K metadata (filings-1, filings-2) is weak evidence and cannot be used to overturn the substantive quarterly financials; its parse status limits its informational value.
Chair's verdict, claim by claim
Fragility · computed, not argued
balanced0.49
18 surviving claims rest on 4 distinct sources; the heaviest analyst carries 33% of them, and 100% of what the desk raised survived the debate.
Eighteen surviving claims supported by only four distinct source types indicates moderate source breadth but meaningful source concentration; the read can be informative but is not widely diversified. One analyst accounting for a third of the surviving claims increases analyst-dependence risk, and the fact that everything the desk raised survived the debate suggests low pushback (which can inflate confidence). Taken together, these factors mean the current synthesis should be treated as useful evidence-level information but relatively fragile to new or contradictory documents.
Disconfirming evidence · base rates · falsifiers
Context
Outside consensus, and where this name already sits in your own portfolio.
Third-party consensus shown for context. It never enters Moneyta sentiment — when the two diverge, the debate above is where the why lives.
What this was built from
Every figure on this page traces to one of these. The desk reads only what is listed here — no outside knowledge, no browsing — and each card shows who read it and what it contributed to the score.
15 filings· 1 cited
SEC XBRL filings
Quarterly figures as filed with the SEC, read straight from EDGAR's structured data — not retyped or estimated.
Read by Mercer+0.7 to the score
1 document
SEC filing documents
The filings themselves, including the year-over-year comparison of Item 1A risk factors.
Read by Oakes+0.0 to the score
1 holdings record
Fund holdings
Which funds hold this name and at what weight, plus insider Form 4 filings.
Read by Ellis+0.3 to the score
1 computation
Valuation inputs
TTM cash-flow figures from the company's own XBRL filings, priced with the stored closing price. Implied growth and multiples only; no fair-value dollar figure reaches the desk, by design.
Read by Archercontext only
1 record· 0 cited
Company profile
Sector, industry and company details.
1 record· 0 cited
Analyst consensus
Third-party consensus, shown for context only — it never enters Moneyta sentiment.
Read means we pulled and handed it to an analyst; cited means a claim on this page points at it. Reading twelve quarters to state one trend is normal — the gap is shown rather than hidden.
Written by AI, checked against sources
The analysts, the bull–bear debate and the editor's note are AI agents reading only the evidence listed on this page. They can misread a filing or a headline, which is why every claim cites a source you can open and check yourself. The sentiment score is arithmetic over the claims that survived the debate, not a language model's opinion.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations. Past patterns do not indicate future results.
Get this for the tickers you actually hold
Plus the one thing no sample can show: how each name correlates with your portfolio, and what hides inside your funds.
The full terminal on RJF Gold
Who holds it, who's buying, what the Street thinks: live behind the lock, updated as filings land.
Institutional holders
Net institutional flow, Q/Q
Largest holder position
Insider buys, 90 days
Clustered insider value
Street target range
The real figures are for members. Educational analysis, not advice.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations.